| Company Name: |
cjbscvictory |
| Tel: |
13348960310 13348960310 |
| Email: |
3003867561@qq.com |
|
| | Benzo[f][1,7]naphthyridine-8-propanoic acid, 5-amino-2-[2-[4-[2-(3,3-difluoro-3-phosphonopropoxy)ethoxy]-2-methylphenyl]ethyl]- Basic information |
| | Benzo[f][1,7]naphthyridine-8-propanoic acid, 5-amino-2-[2-[4-[2-(3,3-difluoro-3-phosphonopropoxy)ethoxy]-2-methylphenyl]ethyl]- Chemical Properties |
| Boiling point | 829.8±75.0 °C(Predicted) | | density | 1.414±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C, stored under nitrogen | | solubility | 1M NaOH : 50 mg/mL (82.84 mM; ultrasonic and adjust pH to 12 with NaOH) | | form | Solid | | pka | 1.19±0.10(Predicted) | | color | Light yellow to yellow |
| | Benzo[f][1,7]naphthyridine-8-propanoic acid, 5-amino-2-[2-[4-[2-(3,3-difluoro-3-phosphonopropoxy)ethoxy]-2-methylphenyl]ethyl]- Usage And Synthesis |
| Uses | LHC-165 is a TLR7 agonist. LHC-165 has potential to used in study of solid tumors[1][2]. | | IC 50 | TLR7 | | References | [1] Carole Bourquin, et al. Harnessing the immune system to fight cancer with Toll-like receptor and RIG-I-like receptor agonists. Pharmacological Research. 2019 Mar. [2] LHC165. |
| | Benzo[f][1,7]naphthyridine-8-propanoic acid, 5-amino-2-[2-[4-[2-(3,3-difluoro-3-phosphonopropoxy)ethoxy]-2-methylphenyl]ethyl]- Preparation Products And Raw materials |
|